Literature DB >> 15939879

Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.

Jeffrey G Shannon1, Dale Howe, Robert A Heinzen.   

Abstract

Coxiella burnetii is an obligate intracellular bacterium and the etiological agent of the zoonotic disease Q fever. Acute human Q fever is characterized by flu-like symptoms that, in some cases, can result in a persistent infection that may reactivate months or years after initial exposure. Mechanisms by which this obligate parasite evades clearance by the host immune response during persistent infection are unknown. Here, we characterized the interaction of C. burnetii with dendritic cells (DC), critical components of both innate and adaptive immunity. Human DC were infected with two isogenic C. burnetii strains that differ in LPS length. Infection by the Nine Mile phase I (NMI) strain, which is fully virulent and produces full-length LPS, did not result in DC maturation. In contrast, infection by the avirulent Nine Mile phase II strain, producing a severely truncated LPS, resulted in toll-like receptor 4-independent DC maturation and approximately 10-fold more IL-12 and TNF production. NMI did not actively inhibit DC maturation as NMI-infected DC subsequently matured if treated with Escherichia coli LPS or Nine Mile phase II. Furthermore, removal of LPS from NMI dramatically increased its ability to stimulate DC. We propose a model whereby LPS of virulent C. burnetii masks toll-like receptor ligands from innate immune recognition by DC, thereby allowing replication without significant maturation or inflammatory cytokine production. This immune evasion strategy may allow C. burnetii to persist in an immunocompetent host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939879      PMCID: PMC1150828          DOI: 10.1073/pnas.0501863102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Dendritic cells: sentinels against pathogens.

Authors:  N P-Y Chung; Y Chen; Vera S F Chan; P K H Tam; C-L S Lin
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

2.  Evidence for proteolytic cleavage of the 120-kilodalton outer membrane protein of rickettsiae: identification of an avirulent mutant deficient in processing.

Authors:  T Hackstadt; R Messer; W Cieplak; M G Peacock
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Steric hindrance of antibody binding to surface proteins of Coxiella burnetti by phase I lipopolysaccharide.

Authors:  T Hackstadt
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.

Authors:  S Vishwanath; T Hackstadt
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis.

Authors:  F T Koster; J C Williams; J S Goodwin
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

7.  Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.

Authors:  Junji Uehori; Misako Matsumoto; Shoutaro Tsuji; Takashi Akazawa; Osamu Takeuchi; Shizuo Akira; Tsutomu Kawata; Ichiro Azuma; Kumao Toyoshima; Tsukasa Seya
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production.

Authors:  Heli Uronen-Hansson; Liana Steeghs; Jennifer Allen; Garth L J Dixon; Mohamed Osman; Peter van der Ley; Simon Y C Wong; Robin Callard; Nigel Klein
Journal:  Cell Microbiol       Date:  2004-07       Impact factor: 3.715

9.  Maturation of the Coxiella burnetii parasitophorous vacuole requires bacterial protein synthesis but not replication.

Authors:  Dale Howe; Jana Melnicáková; Imrich Barák; Robert A Heinzen
Journal:  Cell Microbiol       Date:  2003-07       Impact factor: 3.715

10.  Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates.

Authors:  T Hackstadt
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

View more
  61 in total

1.  Coxiella burnetii alters cyclic AMP-dependent protein kinase signaling during growth in macrophages.

Authors:  Laura J MacDonald; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

3.  The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates.

Authors:  Daniel E Voth; Paul A Beare; Dale Howe; Uma M Sharma; Georgios Samoilis; Diane C Cockrell; Anders Omsland; Robert A Heinzen
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

4.  Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.

Authors:  Stephen R Lindemann; Kaitian Peng; Matthew E Long; Jason R Hunt; Michael A Apicella; Denise M Monack; Lee-Ann H Allen; Bradley D Jones
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

5.  Coxiella burnetii antigen-stimulated dendritic cells mediated protection against Coxiella burnetii in BALB/c mice.

Authors:  Yan Wei; Xile Wang; Xiaolu Xiong; Bohai Wen
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 6.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

7.  Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages.

Authors:  Daniel E Voth; Dale Howe; Robert A Heinzen
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

8.  Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii.

Authors:  Joseph G Graham; Caylin G Winchell; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

9.  Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.

Authors:  Reginaldo G Bastos; Zachary P Howard; Aoi Hiroyasu; Alan G Goodman
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

Review 10.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.